A high-throughput monoamine oxidase inhibition assay using liquid chromatography with tandem mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 18, Issue 8, 2004, Pages 834-840

  Yan, Zhengyin ^a   Caldwell, Gary W ^a   Zhao, Boyu ^a   Reitz, Allen B ^a  

^a LLC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG PRODUCTS; HIGH PRESSURE LIQUID CHROMATOGRAPHY; THROUGHPUT;

HIGH THROUGHPUT SCREENING; HIGH-THROUGHPUT; HYDROXYQUINOLINES; INHIBITION ASSAYS; INTRAMOLECULAR CONDENSATION; LC-MS-MS; LIQUID CHROMATOGRAPHY WITH TANDEM MASS SPECTROMETRY (LCMS/MS); MONOAMINE OXIDASE; MONOAMINE OXIDASE A; MONOAMINE OXIDASE B;

MASS SPECTROMETRY;

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; AMITRIPTYLINE; CLORGYLINE; FLUOXETINE; KYNURAMINE; MONOAMINE OXIDASE A INHIBITOR; MONOAMINE OXIDASE B INHIBITOR; MONOAMINE OXIDASE INHIBITOR; N (2 AMINOETHYL) 5 (3 FLUOROPHENYL) 4 THIAZOLECARBOXAMIDE; QUINOLINE DERIVATIVE; RO 411049; SELEGILINE; TRANYLCYPROMINE;

ARTICLE; DEAMINATION; DIAGNOSTIC VALUE; DRUG EFFECT; DRUG SCREENING; ENZYME ACTIVITY; ENZYME INHIBITION; IC 50; INCUBATION TIME; LIQUID CHROMATOGRAPHY; POLYMERIZATION; TANDEM MASS SPECTROMETRY;

EID: 1942438589     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.1415     Document Type: Article

References (20)

1. Bach AWJ, Lan NC, Johnson DL, Abell CW, Bembenck ME, Kwan SW, Seeburg PH, Shih JC. Proc. Natl Acad. Sci. USA 1988; 85: 4934.
2. Johnson JP. Biochem. Pharmacol. 1968; 17: 1285.
3. Cesura AM, Bos M, Galva MD, Kettler R, Ad Prada M. Mol. Pharmacol. 1989; 20: 358.
4. Knoll J, Magyar K. Adv. Biochem. Psychopharmacol. 1972; 5: 393.
5. Cesura AM, Imhof R, Galva MD, Kettler R, Ad Prada M. Pharmacol. Res. Commun. 1988; 20: 51.
6. Baldessarini RJ. Goodman & Gilman's The Pharmacological Basis of Therapeutics, Hardman JG, Limbird LE (eds). McGraw-Hill: New York, 2001; 447-483.
7. Nicotra A, Parvez SH. Biogenic Amines 1999; 15: 307.
8. Tipton KF, Youdim MBH. Methods in Biogenic Amine Research, Parvez S, Nagatsu T, Nagatsu I, Parvez H (eds). Elsevier: Amsterdam, 1983; 441-465.
9. Zhou M, Panchuk-Voloshina N. Anal. Biochem. 1997; 253: 169.
10. O'Brien EM, Kiely KA, Tipton KF. Biochem. Pharmacol. 1993; 46: 1301.
11. Tabor CW, Tabor H, Rosenthal SM. J. Biol. Chem. 1954; 208: 645.
12. Morinan A, Garratt HM. J. Pharm. Methods 1985; 13: 213.
13. Freeman K, Bulawa MC, Zeng Q, Blank CL. Anal. Biochem. 1993; 208: 182.
14. Wurtman RJ, Axelrod J. Biochem. Pharmacol. 1963; 12: 1439.
15. Yan Z, Caldwell GW, Jones W, Masucci JA. Rapid Comm. Mass Spectrom. 2003; 17: 1433.
16. Krajl M. Biochem. Pharmacol. 1965; 14: 1684.
17. Donnelly C, Murphy DL. Biochem. Pharmacol. 1977; 26: 853.
18. Johnston JP. Biochem. Pharmacol. 1968; 17: 1285.
19. Geha RM, Rebrin I, Chen K, Shih JC. J. Biol. Chem. 2001; 276: 9877.
20. Leonardi ETK, Azmitia EC. Neuropsychopharmacology 1994; 4: 231.